{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:30:54Z","timestamp":1786336254162,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Natural Science Foundation of Jiangxi Province","award":["20242BAB20420"],"award-info":[{"award-number":["20242BAB20420"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04419-y","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:44:56Z","timestamp":1780310696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a machine learning model for predicting distant metastasis in patients with renal cell carcinoma: a population-based study"],"prefix":"10.1186","volume":"24","author":[{"given":"Cheng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongli","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runlin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"3","key":"4419_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4419_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74\u201384.","journal-title":"Eur Urol"},{"issue":"4","key":"4419_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376(4):354\u201366.","journal-title":"N Engl J Med"},{"issue":"9669","key":"4419_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373(9669):1119\u201332.","journal-title":"Lancet"},{"issue":"1","key":"4419_CR5","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4419_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","volume":"20","author":"RJ Motzer","year":"2022","unstructured":"Motzer RJ, Jonasch E, Agarwal N, et al. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(1):71\u201390.","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"4419_CR7","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","volume":"23","author":"JJ Patard","year":"2005","unstructured":"Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23(12):2763\u201371.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4419_CR8","doi-asserted-by":"publisher","first-page":"17822","DOI":"10.1038\/s41598-021-97365-6","volume":"11","author":"H Wei","year":"2021","unstructured":"Wei H, Miao J, Cui J, et al. The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: analysis based on the SEER database. Sci Rep. 2021;11(1):17822.","journal-title":"Sci Rep"},{"issue":"14","key":"4419_CR9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347\u201358.","journal-title":"N Engl J Med"},{"issue":"3","key":"4419_CR10","doi-asserted-by":"publisher","first-page":"e25635","DOI":"10.2196\/25635","volume":"9","author":"JH Park","year":"2021","unstructured":"Park JH, Byun HK, Kim N, et al. Machine learning approach to predict the probability of recurrence of renal cell carcinoma after surgery. JMIR Med Inf. 2021;9(3):e25635.","journal-title":"JMIR Med Inf"},{"issue":"3","key":"4419_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ijc.33288","volume":"148","author":"S Chen","year":"2021","unstructured":"Chen S, Zhang N, Jiang L, et al. Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma. Int J Cancer. 2021;148(3):780\u201390.","journal-title":"Int J Cancer"},{"issue":"9","key":"4419_CR12","doi-asserted-by":"publisher","first-page":"e10578","DOI":"10.1016\/j.heliyon.2022.e10578","volume":"8","author":"S Chen","year":"2022","unstructured":"Chen S, Zhang N, Jiang L, et al. Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma. Heliyon. 2022;8(9):e10578.","journal-title":"Heliyon"},{"key":"4419_CR13","first-page":"4765","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst. 2017;30:4765\u201374.","journal-title":"Adv Neural Inf Process Syst"},{"issue":"6","key":"4419_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamasurg.2018.0501","volume":"153","author":"KM Doll","year":"2018","unstructured":"Doll KM, Rademaker A, Sosa JA. Practical guide to surgical data sets: Surveillance, Epidemiology, and End Results (SEER) database. JAMA Surg. 2018;153(6):588\u20139.","journal-title":"JAMA Surg"},{"key":"4419_CR15","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. 8th ed. Springer; 2017."},{"issue":"9","key":"4419_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/sim.3841","volume":"29","author":"L Desquilbet","year":"2010","unstructured":"Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037\u201357.","journal-title":"Stat Med"},{"issue":"1","key":"4419_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338.","journal-title":"Epidemiology"},{"key":"4419_CR18","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. Wiley; 2000.","DOI":"10.1002\/0471722146"},{"issue":"3","key":"4419_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"6","key":"4419_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26(6):565\u201374.","journal-title":"Med Decis Mak"},{"key":"4419_CR21","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.","journal-title":"BMJ"},{"key":"4419_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.euros.2023.04.011","volume":"52","author":"A Pecoraro","year":"2023","unstructured":"Pecoraro A, Roussel E, Amparore D, et al. New-onset Chronic Kidney Disease After Surgery for Localised Renal Masses in Patients with Two Kidneys and Preserved Renal Function: A Contemporary Multicentre Study. Eur Urol Open Sci. 2023;52:100\u20138.","journal-title":"Eur Urol Open Sci"},{"key":"4419_CR23","first-page":"873014","volume":"12","author":"Z Feng","year":"2022","unstructured":"Feng Z, Shen Q, Li Y, et al. Deep learning model for predicting recurrence in clear cell renal cell carcinoma. Front Oncol. 2022;12:873014.","journal-title":"Front Oncol"},{"issue":"3","key":"4419_CR24","first-page":"100087","volume":"36","author":"A Buchner","year":"2023","unstructured":"Buchner A, Tolkach Y, Paner GP, et al. Multi-institutional validation of AI-assisted grading for renal cell carcinoma. Mod Pathol. 2023;36(3):100087.","journal-title":"Mod Pathol"},{"issue":"2","key":"4419_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(12)70559-4","volume":"14","author":"DY Heng","year":"2013","unstructured":"Heng DY, Xie W, Regan MM, et al. External validation and comparison with other models of the IMDC prognostic model: a population-based study. Lancet Oncol. 2013;14(2):141\u20138.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4419_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1470-2045(14)71222-7","volume":"16","author":"JJ Ko","year":"2015","unstructured":"Ko JJ, Xie W, Kroeger N, et al. The IMDC model as a prognostic tool in previously treated metastatic RCC. Lancet Oncol. 2015;16(3):293\u2013300.","journal-title":"Lancet Oncol"},{"issue":"12","key":"4419_CR27","first-page":"832","volume":"39","author":"A Uhlig","year":"2021","unstructured":"Uhlig A, Uhlig J, Trojan L, et al. Survival prediction in kidney cancer using SEER data and machine learning. Urol Oncol. 2021;39(12):832.e1-832.e7.","journal-title":"Urol Oncol"},{"issue":"6","key":"4419_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.eururo.2018.08.008","volume":"74","author":"A Bex","year":"2018","unstructured":"Bex A, Albiges L, Ljungberg B, et al. Updated EAU Guidelines for cytoreductive nephrectomy in synchronous metastatic clear-cell RCC. Eur Urol. 2018;74(6):805\u20139.","journal-title":"Eur Urol"},{"issue":"5","key":"4419_CR29","first-page":"744","volume":"118","author":"U Capitanio","year":"2016","unstructured":"Capitanio U, Suardi N, Matloob R, et al. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in RCC. BJU Int. 2016;118(5):744\u201351.","journal-title":"BJU Int"},{"issue":"4","key":"4419_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.eururo.2016.08.060","volume":"71","author":"MC Mir","year":"2017","unstructured":"Mir MC, Derweesh I, Porpiglia F, et al. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: systematic review and meta-analysis. Eur Urol. 2017;71(4):606\u201317.","journal-title":"Eur Urol"},{"issue":"1","key":"4419_CR31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s41467-021-21068-9","volume":"12","author":"Z Bakouny","year":"2021","unstructured":"Bakouny Z, Braun DA, Shukla SA, et al. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma. Nat Commun. 2021;12(1):808.","journal-title":"Nat Commun"},{"issue":"4","key":"4419_CR32","first-page":"687","volume":"6","author":"A Volpe","year":"2020","unstructured":"Volpe A, Patard JJ. Prognostic factors in chromophobe renal cell carcinoma: a review. Eur Urol Focus. 2020;6(4):687\u201395.","journal-title":"Eur Urol Focus"},{"issue":"5","key":"4419_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2022;82(5):458\u201368.","journal-title":"Eur Urol"},{"issue":"1","key":"4419_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster B, McLernon DJ, van Smeden M, et al. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):230.","journal-title":"BMC Med"},{"issue":"1","key":"4419_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","volume":"20","author":"RJ Motzer","year":"2022","unstructured":"Motzer RJ, Jonasch E, Agarwal N, et al. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(1):71\u201390.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"4419_CR36","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1177\/0284185119881742","volume":"61","author":"B Kocak","year":"2020","unstructured":"Kocak B, Durmaz ES, Kaya OK, et al. Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas. Acta Radiol. 2020;61(6):856\u201364.","journal-title":"Acta Radiol"},{"issue":"6","key":"4419_CR37","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1007\/s00330-020-06666-3","volume":"30","author":"S Ursprung","year":"2020","unstructured":"Ursprung S, Beer L, Bruber A, et al. Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma\u2014a systematic review and meta-analysis. Eur Radiol. 2020;30(6):3558\u201366.","journal-title":"Eur Radiol"},{"issue":"2","key":"4419_CR38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11864-019-0611-z","volume":"20","author":"P Bergerot","year":"2019","unstructured":"Bergerot P, Hahn AW, Bergerot CD, et al. The role of circulating tumor DNA in renal cell carcinoma. Curr Treat Options Oncol. 2019;20(2):14.","journal-title":"Curr Treat Options Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04419-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04419-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04419-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:21:43Z","timestamp":1786335703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04419-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4419"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04419-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study used de-identified data from the publicly accessible Surveillance, Epidemiology, and End Results (SEER) database. In accordance with the exemption provisions of the U.S. Department of Health and Human Services regulations for the protection of human subjects (45 CFR 46.104(d)(4)), formal ethical approval from an Institutional Review Board (IRB) was not required for this secondary analysis of a publicly available, de-identified dataset. The SEER program has obtained appropriate ethics approval and informed consent from all contributing registries at the point of data collection.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is based entirely on publicly available, de-identified data from the SEER database. No individual patient contact or recruitment was involved, and therefore individual informed consent was not required.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"328"}}